Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events symbols : Bcli save search
BrainStorm Cell Therapeutics Presents NurOwn® Phase 2 Progressive MS Biomarker Data at the 38th ECTRIMS Congress
Published: 2022-10-20 (Crawled : 11:00) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: -0.87%
H: 1.17%
C: -7.29%
nurown biomarker therapeutics phase 2
BrainStorm Announces Presentations at June 2022 Scientific Conferences
Published: 2022-05-31 (Crawled : 12:00) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: -3.29%
H: 4.08%
C: 0.0%
BrainStorm Cell Therapeutics to Present at the 12th Annual California ALS Research Summit
Published: 2022-01-27 (Crawled : 19:00) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: 1.31%
H: 0.32%
C: -5.16%
als california research therapeutics cel
BrainStorm Cell Therapeutics to Present New Biomarker Data on NurOwn® at the International Symposium on ALS/MND
Published: 2021-12-02 (Crawled : 12:30) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: -0.8%
H: 1.61%
C: -6.45%
nurown therapeutics als symposium biomarkers
Phase 2 Clinical Trial Data of NurOwn® in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Published: 2021-10-14 (Crawled : 12:15) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: -3.38%
multiple sclerosis treatment phase 2 europe sclerosis research trial
BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa
Published: 2021-10-04 (Crawled : 11:00) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: -2.47%
Brainstorm Announces Expansion of NurOwn® IP Portfolio with Grant and Allowance of Multiple Patents and Applications in Major Markets
Published: 2021-06-15 (Crawled : 21:00) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: 1.02%
H: 1.08%
C: 0.51%
expansion patent application granted grant
BrainStorm to Present at SVB Leerink 10th Global Healthcare Conference
Published: 2021-02-23 (Crawled : 18:00) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: -8.23%
H: 2.31%
C: 0.17%
conference presentation
BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn® Derived Exosome-Based Treatment for COVID-19 ARDS
Published: 2021-01-20 (Crawled : 00:00) - biospace.com/
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: 2.08%
H: 3.89%
C: -3.7%
covid treatment potential preclinical pre-clinical
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.